ABUS vs TSLA · P/E 5.4, rev $6.2M vs P/E 179, rev $94.83B
Arbutus Biopharma Corp (ABUS) versus Tesla Inc (TSLA) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Tesla Inc (TSLA) is a auto manufacturers company listed on US. It is led by Elon Musk.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported TSLA revenue for 2025-12-31 was $94.83B. Net income was $3.79B. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. TSLA currently screens at market cap $976.12B and trailing P/E 179.1.
Not investment advice. Open the ABUS and TSLA stock pages for the full models.
Not investment advice.